People news: Pfizer, Bausch & Lomb, Sanofi-Aventis, Human Genome Sciences

Share this article:
Pfizer's board of directors elected George Lorch as non-executive chairman of the board. Lorch has been an independent director since 2000 and is chairman emeritus of Armstrong Holdings, a manufacturer of flooring and ceiling materials.

Bausch & Lomb named Daniel Wechsler corporate VP and global president, pharma business. Wechsler joins Bausch & Lomb from Merck, where he was head of US strategy, commercial model innovation and business development.

Sanofi-Aventis named Dr. Elias Zerhouni president, global research and development for medicines and vaccines, and said EVP R&D Marc Cluzel, MD, PhD will resign his post but continue to advise Dr. Zerhouni, who has served as a scientific adviser to CEO Chris Viehbacher since 2009.

Human Genome Sciences named former OSI Pharmaceuticals chief Colin Goddard, PhD to its board of directors.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions